Harren Jhoti (born 1962) FRS FMedSci FRSB FRSC is a structural biologist whose main interest has been rational drug design. He is President & Chief Executive Officer (CEO) of Astex Pharmaceuticals in Cambridge, a biotechnology company he co-founded with Tom Blundell and Chris Abell in 1999. He pioneered the development of fragment-based lead discovery, an approach now widely used in industry and academia to discover new medicines.
Born |
1962 (age 63) India
|
Zodiac | |
Tags | Add tag |